Profound Medical Corp. PRN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.74M | -38.90M | -42.57M | -39.34M | -40.73M |
| Total Depreciation and Amortization | 491.00K | 497.00K | 560.00K | 689.00K | 756.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.07M | 5.59M | 5.52M | 4.64M | 3.64M |
| Change in Net Operating Assets | -8.92M | -5.70M | -1.71M | -3.51M | 1.61M |
| Cash from Operations | -36.10M | -38.51M | -38.21M | -37.52M | -34.73M |
| Capital Expenditure | -176.00K | -176.00K | -176.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.00K | -66.00K | -66.00K | -- | -- |
| Cash from Investing | -242.00K | -242.00K | -242.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -290.00K | -1.03M | -1.62M |
| Issuance of Common Stock | 42.44M | 42.44M | 42.44M | 39.21M | 39.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.02M | -1.02M | -1.02M | -3.04M | -3.04M |
| Cash from Financing | 41.43M | 41.43M | 41.14M | 35.15M | 34.55M |
| Foreign Exchange rate Adjustments | -2.01M | 1.18M | 2.12M | 78.00K | 1.30M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.08M | 3.86M | 4.81M | -2.30M | 1.12M |